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For a long time, it has been assumed that the mode of action of Cry2A toxins was unique and different
from that of other three-domain Cry toxins due to their apparent nonspecific and unsaturable binding to
an unlimited number of receptors. However, based on the homology of the tertiary structure among
three-domain Cry toxins, similar modes of action for all of them are expected. To confirm this hypothesis,
binding assays were carried out with 125I-labeled Cry2Ab. Saturation assays showed that Cry2Ab binds in
a specific and saturable manner to brush border membrane vesicles (BBMVs) of Helicoverpa armigera.
Homologous-competition assays with 125I-Cry2Ab demonstrated that this toxin binds with high affinity to
binding sites in H. armigera and Helicoverpa zea midgut. Heterologous-competition assays showed a
common binding site for three toxins belonging to the Cry2A family (Cry2Aa, Cry2Ab, and Cry2Ae), which
is not shared by Cry1Ac. Estimation of Kd (dissociation constant) values revealed that Cry2Ab had around
35-fold less affinity than Cry1Ac for BBMV binding sites in both insect species. Only minor differences
were found regarding Rt (concentration of binding sites) values. This study questions previous interpre-
tations from other authors performing binding assays with Cry2A toxins and establishes the basis for the
mode of action of Cry2A toxins.
Insecticidal proteins from Bacillus thuringiensis constitute
the active ingredient in many biological insecticides and bio-
tech crops expressing B. thuringiensis genes (Bt crops). For the
control of lepidopteran pests, B. thuringiensis Cry1 and Cry2
class proteins are being used either in sprayable products or in
transgenic plants (16, 40). Most extensively planted Bt crops
express Cry1Ab (maize) or Cry1Ac (cotton), but second-gen-
eration products include the combination of Cry1Ac and
Cry2Ab in cotton (16). In all cases, B. thuringiensis proteins act
by ingestion, and their mode of action is so specific that they
are harmless to most nontarget organisms, beneficial insects,
and vertebrates (38).
The mode of action of Cry proteins has been studied for over
20 years, using a small number of selected Cry proteins be-
longing mainly to the Cry1 family, and a general model has
been accepted (21, 40). After ingestion of the Cry protein, the
solubilized protoxin is proteolytically processed to render a
stable active fragment which crosses the peritrophic membrane
and binds to specific sites in the brush border membrane.
Specific binding is the crucial step in the mode of action for the
exquisite specificity of Cry proteins (46), and binding site al-
teration on midgut cells is the main mechanism conferring high
levels of resistance to Cry proteins in insect populations (15,
16). There is strong evidence that, after binding, Cry1A pro-
teins form oligomers which insert into the midgut epithelium,
causing cell lysis (8, 42), though the involvement of a signaling
pathway has also been proposed (48, 49).
The structures of the three-domain Cry proteins Cry1Aa,
Cry2Aa, Cry3Aa, Cry3Bb, Cry4Aa, and Cry4Bb have been
determined by X-ray crystallography, and all these proteins
share a striking three-dimensional similarity, indicating sim-
ilar functions of their three domains (reviewed in references
10 and 37). Saturable binding to specific receptors has been
shown amply with Cry1 proteins (reviewed in reference 37)
and more limitedly with the coleopteran-active Cry3A (6,
30, 34, 41) and the dipteran-specific Cry4 and Cry11 class
proteins (1, 11, 31, 35). In contrast, an early study of the
mode of action of Cry2Aa proposed a unique mode of action
for this protein in that binding was nonsaturable (13). The
authors concluded that Cry2Aa “might bind to an essentially
unlimited number of relatively low affinity sites” (13). The
nonsaturable nature of Cry2A binding has been assumed or
reiterated in subsequent reports (22, 23, 24). However, a
close inspection of the published results reveals a contra-
diction with the assumption of nonsaturable binding (3, 23,
24, 25, 28).
Taking into account the species-specific toxicity of Cry2A
proteins (25, 26), the above-referenced published data on
Cry2Aa binding analyses, and the strikingly similar three-di-
mensional structures of this protein and the other three-do-
main Cry proteins, we hypothesized that Cry2A proteins would
likely also bind saturably and with high affinity to specific sites
in the midgut epithelium. The goals of the present study were
to show that Cry2Ab binds saturably to specific sites in Heli-
coverpa armigera and Helicoverpa zea, two important cotton
pests which are targets of the second-generation cotton ex-
pressing B. thuringiensis Cry1Ac and Cry2Ab, and to determine
whether such sites are shared with other Cry proteins, such as
Cry1Ac, Cry2Aa, and Cry2Ae.
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MATERIALS AND METHODS
Toxin purification and activation of Cry1Ac and Cry2Ab toxins. B. thuringien-
sis strain HD73 from the Bacillus Genetic Stock Collection (Columbus, OH)
expressing Cry1Ac was grown in casein hydrolysate-yeast extract medium (44)
at 28.5°C with continuous shaking and air supplementation for 48 h. The
pelleted insoluble fraction was washed twice with 1 M NaCl, 10 mM EDTA
and once with 10 mM KCl. Cry1Ac crystals were solubilized in freshly pre-
pared carbonate buffer (50 mM Na2CO3-NaHCO3, 10 mM dithiothreitol, pH
10.5) and incubated at room temperature with shaking at 150 rpm for 2.5 h.
Insoluble debris was discarded by centrifugation at 25,000  g for 10 min at
4°C. The solubilized Cry1Ac protoxin was activated by incubation with trypsin
(Sigma T-8642) with a trypsin-to-protein ratio of 1:10 (wt/wt) at 37°C for 2 h.
After centrifugation at 25,000  g for 10 min at 4°C, the supernatant was
dialyzed in buffer A (20 mM Tris-HCl, pH 8.65) and filtered prior to anion-
exchange purification in a MonoQ 5/5 column using an A¨KTA chromatogra-
phy system (GE Healthcare, United Kingdom). A continuous gradient of
buffer B (20 mM Tris-HCl, 1 M NaCl, pH 8.65), up to 60%, was used to elute
the Cry1Ac-activated toxin.
Strain ECE126 from the Bacillus Genetic Stock Collection (Columbus, OH)
expressing Cry2Aa was grown and activated as Cry1Ac except that solubilization
was performed in NEE buffer (50 mM Na2CO3, 5 mM EDTA, 10 mM EGTA,
pH 12.1). The activated Cry2Aa protein showed an apparent molecular mass
between 55 and 60 kDa by sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE).
The recombinant B. thuringiensis strain IPS78/11 expressing Cry2Ab2 was
grown in C2 medium (12) containing 6 g/ml chloramphenicol at 28°C with
shaking at 80 rpm for 47 h. Following two wash steps in phosphate-buffered
saline (PBS; 8 mM Na2HPO4, 2 mM KH2PO4, 150 mM NaCl, pH 7.4) to which
250 mM NaCl was added, the cell pellet was solubilized in NEE buffer. Trypsin
was added to a final concentration of 0.3 mg/ml out of freshly prepared 25 mg
trypsin/ml, and the mixture was incubated at 37°C for 75 min and centrifuged.
The activated Cry2Ab protein showed an apparent molecular mass slightly less
than 50 kDa by SDS-PAGE. The Cry2Ab toxin solution was precipitated with
ammonium sulfate, and the resulting pellet was dissolved in TEE buffer (50 mM
Tris-HCl, 5 mM EDTA, 10 mM EGTA, pH 8.6).
The recombinant B. thuringiensis subsp. berliner 1715 Cry mutant (Institut
Pasteur, Paris, France) harboring plasmid pGA32 expressing Cry2Ae was
grown in C2 medium containing erythromycin at 20 g/ml at 28°C with
shaking at 80 rpm for 144 h. Following two wash steps in PBS plus 250 mM
NaCl, the cell pellet was solubilized in alkaline buffer (0.1 M CAPS [3-(cy-
clohexylamino)-1-propanesulfonic acid], 10 mM EGTA, 5 mM EDTA, pH
12.0) and incubated for 1 h at 37°C. Trypsin was added (at a 3:1 [wt/wt] ratio)
out of freshly prepared 7.5 mg trypsin/ml, and the mixture was incubated
overnight at 37°C and centrifuged. The activated Cry2Ae protein showed an
apparent molecular mass of about 60 kDa by SDS-PAGE. The Cry2Ae toxin
solution was dialyzed against PBS.
Bioassays. Seven different concentrations of activated Cry1Ac and Cry2Ab
proteins were tested using 16 neonate larvae of H. armigera for each concentra-
tion. A volume of 50 l of the sample dilutions was applied on the surface of the
artificial diet dispensed in multiple-well plates. One larva was placed in each well.
The plates were incubated at 25  2°C, with a relative humidity of 65%  5%
and a photoperiod of 16 h:8 h (light/dark). Mortality was evaluated after 7 days.
Toxicity data were analyzed using the POLO-PC probit analysis program (LeOra
Software, Berkeley, CA).
Midgut isolation and BBMV preparation. Last-instar larvae of H. armigera
(ANGR strain; CSIRO Entomology, Australia) and H. zea (USDA-ARS,
Stoneville, MS) were dissected, and the midguts were preserved at 80°C until
required. Brush border membrane vesicles (BBMVs) were prepared by the
differential magnesium precipitation method (47), frozen in liquid nitrogen, and
stored at 80°C. The protein concentration in the BBMV preparations was
determined by the Bradford method (7) using bovine serum albumin (BSA) as
standard.
Radiolabeling of Cry toxins. Cry1Ac and Cry2Ab toxins were labeled using the
chloramine T method. Na125I (0.5 mCi) (PerkinElmer, Boston, MA) was added
to 25 g of Cry toxin in the presence of 1/3 (vol/vol) of 18 mM of chloramine T
in PBS. After incubation for 45 s, the reaction was stopped by the addition of 1/4
(vol/vol) of 23 mM potassium metabisulfite in H2O. Finally, 1/4 (vol/vol) of 1 M
NaI was added, and the mixture was loaded onto a PD10 desalting column (GE
HealthCare, United Kingdom) equilibrated with column buffer (20 mM Tris-
HCl, 150 mM NaCl, 0.1% BSA). The purity of the labeled protein was checked
by analyzing the elution fractions by SDS-PAGE with further exposure of the dry
gel to an X-ray film. The specific activity of the labeled toxin was calculated based
on the input toxin, the radioactivity eluting in the protein peak, and the percent-
age of radioactivity in the toxin band versus that in minor bands as revealed by
SDS-PAGE (Fig. 1). The estimated specific activities of 125I-Cry1Ac and 125I-
Cry2Ab toxins were 3 mCi/mg and 2.4 mCi/mg, respectively.
Binding assays with 125I-labeled Cry1Ac and Cry2Ab. Prior to being used,
BBMVs were centrifuged for 10 min at 16,000  g and resuspended in binding
buffer (8 mM Na2HPO4, 2 mM KH2PO4, 150 mM NaCl, pH 7.4, 0.1% BSA).
Saturation experiments were carried out by incubating 20 g of BBMVs from H.
armigera with increasing amounts of 125I-Cry2Ab in binding buffer for 1 h at
25°C. After incubation, samples were centrifuged at 16,000  g for 10 min and
the pellet was washed twice with 500 l of cold binding buffer. The radioactivity
retained in the pellet was measured in an LKB 1282 Compugamma CS gamma
counter. Nonspecific binding was determined by adding an excess of unlabeled
Cry2Ab (1 M) to the reaction mixture. Specific binding was calculated by
subtracting the nonspecific binding from the total binding.
To determine the optimal concentration of BBMVs for use in competition
experiments, increasing amounts of BBMVs were incubated with 0.4 nM and 1.2
nM of labeled Cry1Ac and Cry2Ab, respectively, in a final volume of 0.1 ml of
binding buffer for 1 h at 25°C. An excess of unlabeled toxin was used to calculate
the nonspecific binding.
Competition experiments were done by incubating either 20 g of BBMVs and
1 nM 125I-Cry2Ab or 5 g of BBMVs and 0.6 nM 125I-Cry1Ac for 1 h at 25°C in
the presence of increasing amounts of unlabeled toxins. For quantitative assays,
the fraction of labeled toxin bound to BBMVs was determined in a gamma
counter. The dissociation constant (Kd) and concentration of binding sites (Rt)
were calculated using the LIGAND program (33). For qualitative assays, pellets
were boiled for 10 min in loading buffer and run in SDS-PAGE. The labeled
toxin retained in the pellet was detected by autoradiography after a 1-week
exposure.
RESULTS
Toxicity of Cry1Ac and Cry2Ab proteins to H. armigera. The
toxicity of the Cry1Ac and Cry2Ab preparations was tested.
FIG. 1. Autoradiography of 125I-Cry2Ab binding to BBMVs from
H. armigera. 125I-Cry2Ab was incubated with BBMVs in the absence or
presence of an excess of competitor, and the pellet produced from
centrifuging the binding reaction mixture was subjected to SDS-PAGE
and exposed to an X-ray film for a week. Lane 1, 125I-Cry2Ab toxin;
lane 2, 125I-Cry2Ab incubated with BBMVs in the absence of compet-
itor; lane 3, homologous competition (excess of unlabeled Cry2Ab);
lane 4, heterologous competition with Cry1Ac.
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Activated Cry1Ac and Cry2Ab proteins were toxic to H. ar-
migera larvae, and the 50% lethal concentrations are shown in
Table 1.
Specific binding of 125I-Cry2Ab to H. armigera BBMVs. As a
first approach, specific binding of Cry2Ab was tested by incu-
bating BBMVs from H. armigera with radiolabeled Cry2Ab
(Fig. 1). Although other labeled contaminants were present in
the 125I-Cry2Ab preparation, only the band corresponding to
Cry2Ab bound to the BBMVs. An excess of unlabeled Cry2Ab
drastically reduced the binding of 125I-Cry2Ab, indicating that
most of this binding was specific. In contrast, an excess of
unlabeled Cry1Ac did not decrease the binding of labeled
Cry2Ab, indicating that Cry2Ab binding sites are not recog-
nized by Cry1Ac.
Saturation of 125I-Cry2Ab binding to H. armigera BBMVs.
Binding of Cry2Ab was shown to be saturable by incubating H.
armigera BBMVs with increasing concentrations of labeled
Cry2Ab. Under the conditions used (0.2 mg BBMV protein/
ml), the curve deviated from linearity starting approximately at
5 nM 125I-Cry2Ab and reached a maximum at approximately
20 nM (Fig. 2).
Competition experiments with H. armigera BBMVs. To find
out the optimal concentration of BBMVs for competition
binding experiments, a fixed concentration of 125I-Cry2Ab was
incubated with increasing concentrations of H. armigera
BBMVs. As expected, after subtraction of the nonspecific
binding, an increase in specific binding was observed corre-
sponding to the increase in binding sites (Fig. 3A). A concen-
tration of 0.2 mg/ml of BBMVs was chosen to perform com-
petition binding experiments. A similar experiment carried out
with 125I-Cry1Ac indicated an optimal BBMV concentration of
0.05 mg/ml for competition experiments (data not shown).
The 125I-Cry2Ab displacement observed with unlabeled
Cry2Ab protein in homologous-competition assays confirmed
that binding of Cry2Ab in this insect is specific and saturable
(Fig. 3B). Under our experimental conditions, a high level of
nonspecific binding was observed. Competition binding assays
using Cry2Aa and Cry2Ae as heterologous competitors
showed that these Cry proteins readily competed with 125I-
Cry2Ab (Fig. 3B). In contrast, unlabeled Cry1Ac was unable to
compete for 125I-Cry2Ab binding in the range of concentra-
tions tested (higher concentrations of Cry1Ac than those
shown in Fig. 3B resulted in precipitation of 125I-Cry2Ab).
These results indicate that Cry2Ab binding sites are shared by
the other two Cry2 toxins but not by Cry1Ac.
Competition assays were also carried out with 125I-Cry1Ac
using Cry1Ac, Cry2Ab, Cry2Aa, and Cry2Ae as competitors
(Fig. 3C). None of the Cry2A proteins competed for binding
with 125I-Cry1Ac, confirming the occurrence of different bind-
ing sites for Cry1Ac and these Cry2A proteins.
Binding parameters, Kd and Rt, were calculated for Cry2Ab
and Cry1Ac from homologous-competition curves (Table 2).
In both cases, homologous-competition data fit a single-site
model equation. As shown in Table 2, Cry2Ab has slightly
more specific binding sites than Cry1Ac in H. armigera, but the
affinity of Cry2Ab is lower than the affinity of Cry1Ac for their
respective binding sites.
Radiolabeling of Cry2Ab and Cry1Ac was done twice inde-
FIG. 2. Saturation of 125I-Cry2Ab-specific binding to H. armigera
BBMVs. A fixed amount of BBMVs (20 g of vesicle proteins) was
incubated with increasing amounts of 125I-Cry2Ab for 1 h. The binding
reaction was stopped by centrifugation, and the radioactivity retained
in the pellet was measured. Nonspecific binding was calculated by
incubating with an excess of unlabeled Cry2Ab and subtracted from
the total binding.
FIG. 3. Binding of 125I-Cry2Ab to H. armigera BBMVs. (A) Spe-
cific binding of 125I-Cry2Ab to increasing concentrations of BBMVs.
Nonspecific binding was calculated in the presence of an excess of
unlabeled Cry2Ab. Data points correspond to the mean of five repli-
cates using two independent 125I-Cry2Ab batches. (B) Competition
experiments with 125I-Cry2Ab. (C) Competition experiments with 125I-
Cry1Ac. In competition assays, each data point represents the mean of
at least two independent replicates.
TABLE 1. Toxicity of Cry1Ac- and Cry2Ab-activated proteins to
neonate larvae of H. armigera (measured after 7 days)a
Protein LC50 (ng/cm2) 95% FL Slope  SE
Cry1Ac 123 23–257 1.5  0.3
Cry2Ab 314 112–515 2.6  0.6
a LC50, 50% lethal concentration; FL, fiducial limits at the 95% level.
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pendently, and all the experiments described above were re-
peated with the second preparation of radiolabeled Cry1Ac
and Cry2Ab. Results obtained with the second set of radiola-
beled toxins were similar to those described above.
Specific binding of Cry2Ab to H. zea BBMVs. To confirm the
model of binding sites obtained from experiments for H. ar-
migera, binding assays were also performed for H. zea. In this
insect, specific binding was also observed when increasing
amounts of BBMVs were incubated with 125I-Cry2Ab. The
percentage of bound toxin in H. zea was lower than that in H.
armigera when the same range of BBMV concentrations was
used (compare Fig. 4A and 3A).
125I-Cry2Ab was used to perform homologous- and heterol-
ogous-competition assays for H. zea. As in H. armigera, unla-
beled Cry2Ab competed for 125I-Cry2Ab binding sites (Fig.
4B). The homologous competition indirectly demonstrated sat-
urable binding of Cry2Ab in this insect, since the curve reflects
a limited number of binding sites in the concentration range of
unlabeled competitor. As in H. armigera, about half of the total
binding corresponded to nonspecific binding. In the heterolo-
gous-competition assay, Cry1Ac did not compete with 125I-
Cry2Ab.
Experiments with 125I-Cry1Ac showed no competition of
Cry2Ab for Cry1Ac binding sites (Fig. 4C), demonstrating the
existence of different binding sites for Cry2Ab and Cry1Ac also
in H. zea.
DISCUSSION
The first and only in-depth study so far carried out on the
mode of action of Cry2A proteins was done by English et al.
(13), using Cry2Aa and H. zea BBMVs. In that study, English
et al. proposed that Cry2Aa binding was nonsaturable, suggest-
ing that this toxin binds to an unlimited number of low-affinity
sites and setting forward the idea that this was a unique mode
of action among -endotoxins. However, we hypothesized that
the mode of action of Cry2A toxins, and in particular the
binding step, would in fact be quite similar to that of other Cry
toxins. First, like other Cry toxins, Cry2A crystal inclusions can
be solubilized to inactive protoxins that become active toxins
upon proteolytic cleavage (5). Second, the global tertiary struc-
ture of Cry2Aa is strikingly similar to those of Cry1Aa,
Cry3Aa, Cry3Bb, Cry4Aa, and Cry4Bb (10). In that sense, the
three-domain organization shared by Cry proteins is also
present in Cry2A toxins, suggesting that Cry2A proteins may
display functional properties similar to those of other Cry
proteins. The N-terminal domain of Cry2A proteins contains a
bundle of  helices that likely act as a transmembrane region
(27, 32). This feature is related to the final step in the mode of
action of Cry toxins: the insertion of the toxin into the mi-
crovilli of apical membranes that leads to the formation of lytic
pores (4, 9). A putative receptor binding epitope in domain II
of Cry2A has been predicted (32). This domain is implicated in
binding to specific sites in Cry1A toxins (9). Third, Cry2A
proteins also display a restricted spectrum of toxicity, which
appears difficult to reconcile with nonspecific binding. Based
on these observations, we wanted to verify if Cry2A proteins do
indeed bind nonsaturably, as proposed originally by English et
al. (13) and later by other authors as well.
Saturation binding experiments carried out with Cry2Ab
showed that there are a limited number of specific receptors in
the membrane of H. armigera midgut cells. An analogous sat-
uration assay with labeled Cry1Ac revealed that, with the same
concentration of BBMVs, saturation of binding sites was
achieved using four times less toxin than that in the Cry2Ab
assay (data not shown). Our results are in contrast with previ-
ous results from Cry2Aa saturation binding assays which sug-
gested nonsaturable binding (13, 22). There are a number of
potential explanations for the observation of a more- or less-
linear curve in those Cry2Aa saturation experiments. First,
these authors used labeled Cry2Aa protoxins rather than acti-
vated toxins. Moreover, in one study, the labeling was per-
formed with denatured Cry2Aa protein, whereas it was not
FIG. 4. Binding of 125I-Cry2Ab to H. zea BBMVs. (A) Specific
binding of 125I-Cry2Ab to increasing concentrations of BBMVs. Non-
specific binding was calculated in the presence of an excess of unla-
beled Cry2Ab. (B) Competition experiments with 125I-Cry2Ab.
(C) Competition experiments with 125I-Cry1Ac. Each data point rep-
resents the mean of at least two independent replicates.
TABLE 2. Kd and Rt calculated from the homologous-competition
assays with BBMVs from H. armigera and H. zea
Toxin
Mean  SEM fora:
H. armigera H. zea
Kd (nM) Rt (pmol/mg)b Kd (nM) Rt (pmol/mg)b
Cry1Ac 0.08  0.02 0.96  0.10 0.17  0.04 10  2
Cry2Ab 3.1  0.5 2.5  0.3 5.9  1.5 2.7  0.5
a Values for Cry1Ac were obtained from two replicates, and values for Cry2Ab
were obtained from at least four replicates.
b Values are expressed in picomoles per milligram of BBMV protein.
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verified that Cry2Aa can withstand a cycle of denaturation and
renaturation under the conditions used (13). Second, buffers
were used at a pH value at which the Cry2A protoxins are not
soluble (43). In saturation experiments, the low solubility and
tendency to aggregate of Cry2A proteins (36) may lead to a
linear increase of recovered radioactivity due to precipitation.
Third, the concentration range of Cry2Aa toxin used in satu-
ration experiments might not have been sufficient to saturate
binding sites. The range used was the same as that for Cry1Ac
toxin, but due to the lower affinity of Cry2A toxins, a higher
concentration of Cry2Aa toxin may have been required to
show saturation of the binding sites. Fourth, the concentration
of BBMVs used might have been inadequate to distinguish
specific binding. High levels of nonspecific binding of Cry2A
toxins (to vesicle components and/or vials or filters) might have
masked specific binding if the concentration of binding sites
was not high enough.
In some studies with 125I-Cry2A toxins, the BBMV binding
ability assay (i.e., a fixed concentration of labeled toxin and
increasing amounts of BBMVs) has been presented as a 125I-
Cry2A saturation assay (i.e., fixed BBMV concentration and
increasing amounts of labeled toxin) (23, 24, 28). Saturability
of binding sites cannot be determined if the concentration of
binding sites is changing along the experiment. Therefore, the
classification of Cry2A binding as saturable (28) or nonsat-
urable (23, 24) was based on the wrong type of experiment in
these studies. The present study is the first report describing
the saturable binding of a Cry2 toxin based on the proper
saturation experiment.
Homologous-competition assays with Cry2Ab in H. armigera
and H. zea in the present study confirm the existence of a
limited number of binding sites. Indeed, if Cry2A binding was
nonsaturable, there would be an essentially infinite number of
binding sites available for binding, and competition of the
unlabeled toxin with the labeled toxin for these sites would not
be practically possible. In fact, indirect evidence of saturable
binding of Cry2A toxins, even if the original interpretation of
the results was different, has been found in homologous-com-
petition experiments reported for different insect species (3,
23, 24, 25, 28). Nevertheless, in agreement with some of these
studies, a large percentage of Cry2Ab binding in our experi-
ments seems to be nonspecific and, therefore, nonsaturable. It
is very likely, though, that most of the radioactivity catalogued
as nonspecific binding is actually radioactivity coming from
precipitated labeled Cry2Ab. Under our experimental condi-
tions, these two alternatives cannot be distinguished.
The analysis of binding parameters from homologous-com-
petition assays gave Kd values that were around 35 times higher
for Cry2Ab toxin than for Cry1Ac in both Helicoverpa species,
indicating a lower binding affinity of Cry2Ab. However, differ-
ences between toxins in terms of concentration of binding sites
were much lower (around threefold). The Kd values for
Cry2Ab and Cry1Ac calculated from competition assays were
similar to those calculated from saturation experiments in H.
armigera (data not shown). Mandal et al. (29) suggested that
the low receptor binding affinity of Cry2A toxin reported by
some authors is attributed to the presence of an extra N-
terminal region in this toxin.
To our knowledge, this is the first report on binding com-
petition assays among Cry2A proteins. Heterologous-compe-
tition experiments with labeled Cry2Ab and unlabeled Cry2Aa
and Cry2Ae toxins showed that these proteins share common
binding sites in H. armigera. In addition, high-affinity compe-
tition between Cry1Ac and Cry2A proteins in H. armigera and
H. zea was not found, in agreement with results previously
reported (14, 24, 28). In these insects, high-affinity competition
between Cry2A toxins and other toxins belonging to the Cry1A
family was also not found (14, 24, 28). Based on all these
results, we propose for these two Helicoverpa species a model
with independent binding sites for Cry1A and Cry2A toxins.
This model may be extended to other insect species for which
heterologous-competition experiments have shown the ab-
sence of competition between Cry1A and Cry2A toxins (3, 18,
22, 23, 24, 25, 39). In these studies, it was reported that com-
petition either did not occur or occurred only at very high
concentrations of competitor, suggesting that in some cases,
the binding sites of Cry1A toxins may function as low-affinity
binding sites of Cry2A toxins and vice versa.
The model of a common binding site for Cry2A toxins that
is not shared by the common binding site of Cry1A toxins is
supported by cross-resistance studies. No relevant cross-resis-
tance has been found between toxins from these two Cry fam-
ilies in most of the species tested (2, 20, 28, 45). Cross-resis-
tance between Cry1Ac and Cry2Aa has been described only in
Heliothis virescens (17, 19, 22). However, in these studies, al-
teration of a common receptor for Cry1A and Cry2A was
found not to be responsible for resistance, and therefore, a
common mechanism in some other step in the mode of action
of both toxins must be responsible for the observed cross-
resistance.
In summary, our results, in agreement with some indirect
evidence from the other authors discussed above, clearly show
that Cry2A proteins bind saturably and with high affinity to
specific sites in H. armigera and H. zea BBMVs. In addition, the
high-affinity binding sites are shared among Cry2Aa, Cry2Ab,
and Cry2Ae but not with Cry1Ac. This situation is similar to
that of Cry1A proteins, for which at least one common high-
affinity binding site has been reported for Cry1Aa, Cry1Ab,
and Cry1Ac in all insect species tested. The demonstration that
Cry2A proteins have a high-affinity binding site different from
that of Cry1Ac, and most likely from all Cry1A proteins, has
important implications for insect resistance management: it
offers a biochemical explanation of why cross-resistance be-
tween Cry1A and Cry2A proteins is so rare and provides solid
support for the resistance management strategy of combining
cry1A and cry2A genes in the same crop.
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